Cited by 317Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

The DOI matches its Crossref record; 252 of the 258 references it cites were found in a registry or an index.

7. Diabetes Technology: Standards of Care in Diabetes — 2023

Open access

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E., Isaacs, Diana, Johnson, Eric L., Kahan, Scott, Khunti, Kamlesh, Leon, Jose, Lyons, Sarah K., Perry, Mary Lou, Prahalad, Priya, Pratley, Richard E., Seley, Jane Jeffrie, Stanton, Robert C., Gabbay, Robert A.·2023·Diabetes Care

DOI 10.2337/dc23-s007PMC PMC9810474

Open this paper in CoChat — free account Open PDF

Abstract

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dc23-s007

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT): a multicentre international randomised controlled trial
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705

Show all 258 references

Sorted by citations

Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis
Kerr, D., Ahn, D., Waki, K., Wang, J., Breznen, B., & Klonoff, D. C. (2024) · Journal of Medical Internet Research · doi:10.2196/55757 · Cited by 101
“…continuous glucose monitors, and connected insulin pens; digital interventions including mobile apps, SMS text messaging, electronic communications, and videoconference platforms; and wearable technologies for monitoring health, such as activity trackers, sleep trackers, and smartwatches [6,7].”
Diabetes and cirrhosis: Current concepts on diagnosis and management
Castéra, L., & Cusi, K. J. (2023) · Hepatology · doi:10.1097/hep.0000000000000263 · Cited by 87
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
Spanakis, E. K., Cook, C. B., Kulasa, K. M., Aloi, J., Bally, L., Davis, G. M., Dungan, K. M., Galindo, R. J., Mendez, C. E., Pasquel, F. J., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231191104 · Cited by 82
Advances in the management of type 2 diabetes in adults
Galindo, R. J., Trujillo, J. M., Wang, C. C. L., & McCoy, R. G. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000372 · Cited by 90
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 81
Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial
Lind, N., Christensen, M. B., Hansen, D. L., & Nørgaard, K. (2024) · Diabetes Care · doi:10.2337/dc23-2194 · Cited by 73
Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery
Rajan, N., Duggan, E. W., Abdelmalak, B., Butz, S. F., Rodriguez, L. V., Vann, M. A., & Joshi, G. P. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006791 · Cited by 75
Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all
Ebekozien, O., Fantasia, K., Farrokhi, F., Sabharwal, A., & Kerr, D. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15470 · Cited by 70
Nursing in the Digital Age: Harnessing telemedicine for enhanced patient care
David-Olawade, A. C., Olawade, D. B., Ojo, I. O., Famujimi, M. E., Olawumi, T. T., & Esan, D. T. (2024) · Informatics and Health · doi:10.1016/j.infoh.2024.07.003 · Cited by 67
Application of Chatbots to Help Patients Self-Manage Diabetes: Systematic Review and Meta-Analysis
Wu, Y., Zhang, J., Ge, P., Duan, T., Zhou, J., Wu, Y., Zhang, Y.-P., Liu, S., Liu, X., Wan, E., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/60380 · Cited by 73
Real-world evidence of automated insulin delivery system use
Considine, E. G., & Sherr, J. L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0442 · Cited by 59
Digital Technology for Diabetes
Hughes, M. S., Addala, A., & Buckingham, B. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215899 · Cited by 59
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting
Beato-Víbora, P. I., Chico, A. I., Moreno-Fernández, J., Bellido, V., Nattero‐Chávez, L., César, M. J. P., Martínez‐Brocca, M. A., Giménez, M., Aguilera, E., Climent, E., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1355 · Cited by 57
Communication protocols integrating wearables, ingestibles, and implantables for closed-loop therapies
Ghanim, R. W., Kaushik, A., Park, J., & Abramson, A. (2023) · Device · doi:10.1016/j.device.2023.100092 · Cited by 57
Ageing well with diabetes: the role of technology
Maltese, G., McAuley, S. A., Trawley, S. L., & Sinclair, A. J. (2024) · Diabetologia · doi:10.1007/s00125-024-06240-2 · Cited by 56
Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade
Karakus, K. E., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2023) · Diabetes Care · doi:10.2337/dc23-0495 · Cited by 52
Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital
Bellido, V., Freckman, G., Pérez, A., & Galindo, R. J. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.06.007 · Cited by 52
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems
Eichenlaub, M., Pleus, S., Rothenbühler, M., Bailey, T. S., Bally, L., Brazg, R., Bruttomesso, D., Diem, P., Boija, E. E., Fokkert, M. J., et al. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0465 · Cited by 51
Acute and Chronic Adverse Outcomes of Type 1 Diabetes
LONGENDYKE, R. L., Grundman, J., & Majidi, S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.09.004 · Cited by 49
Collagen/chitosan/genipin hydrogel loaded with phycocyanin nanoparticles and ND-336 for diabetic wound healing
Li, Z., Qian, C., Zheng, X., Qi, X., Bi, J., Wang, H., & Cao, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131220 · Cited by 45
Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes
Prahalad, P., Scheinker, D., Desai, M., Ding, V. Y., Bishop, F. K., Lee, M. Y., Ferstad, J. O., Zaharieva, D. P., Addala, A., Johari, R., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02975-y · Cited by 45
Self-citation
Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications
Hölzen, L., Schultes, B., Meyhöfer, S. M., & Meyhöfer, S. (2024) · Biomedicines · doi:10.3390/biomedicines12020391 · Cited by 44
Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen
MacLeod, J., Im, G. H., Smith, M., & Vigersky, R. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0365 · Cited by 44
Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations
Friedman, J. G., Cardona, Z., Szmuilowicz, E. D., & Aleppo, G. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s374663 · Cited by 43
Self-citation
A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial
Dovč, K., Bergford, S., Fröhlich-Reiterer, E. E., Zaharieva, D. P., Potočnik, N., Müller, A., Lenarčič, Ž., Calhoun, P. M., Fritsch, M., Sourij, H., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0178 · Cited by 43
Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring
Klonoff, D. C., Gabbay, M., Moon, S. J., & Wilmot, E. G. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241250357 · Cited by 36
Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking
Aleppo, G., Hirsch, I. B., Parkin, C. G., McGill, J., Galindo, R., Kruger, D. F., Levy, C. J., Forlenza, G. P., Umpierrez, G. E., Grunberger, G., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0268 · Cited by 34
Self-citation
Continuous glucose monitoring for inpatient diabetes management: an update on current evidence and practice
Zelada, H., Perez‐Guzman, M. C., Cherñavvsky, D. R., & Galindo, R. J. (2023) · Endocrine Connections · doi:10.1530/ec-23-0180 · Cited by 34
Key indices of glycaemic variability for application in diabetes clinical practice
Monnier, L., Bonnet, F., Colette, C., Renard, É., & Owens, D. R. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101488 · Cited by 35
Advancing elderly diabetes care: exploring the usability and acceptance of continuous glucose monitoring (CGM)
Ahn, J., Yang, Y., & Park, G. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.06.041 · Cited by 36
Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes
Tanenbaum, M. L., & COMMISSARIAT, P. V. (2023) · Endocrine Connections · doi:10.1530/ec-23-0193 · Cited by 32
Advantages and disadvantages of connected insulin pens in diabetes management
Lingen, K., Pikounis, T., Bellini, N. J., & Isaacs, D. M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0108 · Cited by 33
Self-citation
Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019
LACY, M. E., Lee, K. E., Ataç, Ö., Heier, K., Fowlkes, J. L., Kucharska‐Newton, A., & Moga, D. C. (2024) · Clinical Diabetes · doi:10.2337/cd23-0051 · Cited by 32
Safety and Effectiveness of MiniMed TM 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes
Bhargava, A., Bergenstal, R. M., Warren, M., Thrasher, J. R., Dempsey, M. A., Bode, B. W., LaRocque, J., Carlson, A. L., Keiter, A., Ma, H., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0586 · Cited by 31
Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps
Patel, P. M., Thomas, D., Liu, Z., Renner, S. A., Clemons, M. D., & Patel, B. V. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15774 · Cited by 30
Impact of a combined continuous glucose monitoring-digital health solution on glucose metrics and self-management behavior for adults with type 2 diabetes: real-world, observational study
Kumbara, A. B., Iyer, A. K., Green, C. R., Jepson, L. H., Leone, K., Layne, J. E., & Shomali, M. (2023) · JMIR Diabetes · doi:10.2196/47638 · Cited by 29
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
Thrasher, J. R., Arrieta, A., Niu, F., Cameron, K. R., Cordero, T. L., Shin, J., Rhinehart, A. S., & Vigersky, R. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0453 · Cited by 29
Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models
Lomax, K. E., Taplin, C. E., Abraham, M. B., Smith, G. J., Haynes, A., Zomer, E., Ellis, K. L., Clapin, H. F., Zoungas, S., Jenkins, A. J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1178958 · Cited by 32
Determinants Related to Oxidative Stress Parameters in Pediatric Patients with Type 1 Diabetes Mellitus
Grabia, M., Socha, K., Soroczyńska, J., Bossowski, A. T., & Markiewicz‐Żukowska, R. (2023) · Nutrients · doi:10.3390/nu15092084 · Cited by 27
Comparing the glycaemic outcomes between real‐time continuous glucose monitoring ( rt‐CGM ) and intermittently scanned continuous glucose monitoring ( isCGM ) among adults and children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
Zhou, Y., Sardana, D., Kuroko, S., Haszard, J. J., de Block, M. I., Weng, J., Jefferies, C., & Wheeler, B. J. (2024) · Diabetic Medicine · doi:10.1111/dme.15280 · Cited by 25
Technology in the management of diabetes in hospitalised adults
Thabit, H., & Schofield, J. D. (2024) · Diabetologia · doi:10.1007/s00125-024-06206-4 · Cited by 24
Continuous Glucose Monitor: Reclaiming Type 2 Diabetes Self-efficacy and Mitigating Disparities
Ni, K., Tampe, C. A., Sol, K., Cervantes, L., & Pereira, R. I. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae125 · Cited by 24
Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers
Prahalad, P., Hardison, H., Odugbesan, O., Lyons, S. K., Alwazeer, M., Neyman, A., Miyazaki, B., Cossen, K., Hsieh, S., Eng, D. S., et al. (2023) · Clinical Diabetes · doi:10.2337/cd23-0052 · Cited by 23
Self-citation
Barriers and Facilitators to Uptake of Continuous Glucose Monitoring for Management of Type 2 Diabetes Mellitus in Youth
Peyyety, V., Zupa, M. F., Hewitt, B., Gonzalez, A. R., Mani, I., Prioleau, T., McCurley, J. L., Lin, Y. K., & Vajravelu, M. E. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231205030 · Cited by 25
Expanding the horizon of continuous glucose monitoring into the future of pediatric medicine
Morales-Dopico, L., & MacLeish, S. A. (2024) · Pediatric Research · doi:10.1038/s41390-024-03573-x · Cited by 23
Deep Reinforcement Learning for Automated Insulin Delivery Systems: Algorithms, Applications, and Prospects
Yu, X., Yang, Z., Sun, X., Liu, H., Li, H., Lu, J., Zhou, J. H., & Çınar, A. (2025) · AI · doi:10.3390/ai6050087 · Cited by 23
Effectiveness and Safety of the Intermittently Scanned Continuous Glucose Monitoring System FreeStyle Libre 2 in Patients with Type 2 Diabetes Treated with Basal Insulin or Oral Antidiabetic Drugs: An Observational, Retrospective Real-World Study
Conti, M., Massari, G., Meneghini, E., Pasquino, B., Agosti, B., Chinotti, F., Pintaudi, B., Girelli, A., & Bertuzzi, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030642 · Cited by 21
Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
Pérez, C. T., Chico, A. I., Azriel-Mira, S., Lardiés‐Sánchez, B., Peralta, F. G., de Diabetes-SEEN, T. Á., Jesús, A. F. A., Rodrigo, A. B., Bellido, V., Bellido-Guerrero, D., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01417-1 · Cited by 21
Gender differences in reported frequency and consequences of hypoglycemia among adults living with type 1 diabetes: Results from the BETTER registry
Talbo, M. K., Lebbar, M., Wu, Z., Vanasse, A., Lalanne‐Mistrih, M., Brazeau, A., & RABASA-LHORET, R. P. R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110822 · Cited by 22
‘You have to use everything and come to some equilibrium’: a qualitative study on hypoglycemia self-management in users of continuous glucose monitor with diverse hypoglycemia experiences
Lin, Y. K., Agni, A., Chuisano, S. A., de Zoysa, N., Fetters, M. D., Amiel, S. A., Pop‐Busui, R., & DeJonckheere, M. J. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003415 · Cited by 21
Efficacy of a Digital Educational Intervention for Patients With Type 2 Diabetes Mellitus: Multicenter, Randomized, Prospective, 6-Month Follow-Up Study
Mateos, I. C., Morales, C., López, M. L., & Vilches‐Arenas, Á. (2025) · Journal of Medical Internet Research · doi:10.2196/60758 · Cited by 23
Integration of Continuous Glucose Monitoring Data into an Electronic Health Record System: Single-Center Implementation
Aleppo, G., Chmiel, R., Zurn, A., Bandoske, R., Creamer, P., Neubauer, N., Wong, J., Andrade, S. B., & Hauptman, A. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231196168 · Cited by 19
Self-citation
Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providers
Vimalananda, V. G., Kragen, B., Leibowitz, A. J., Qian, S. X., Wormwood, J. B., Linsky, A. M., UNDERWOOD, P. C., Conlin, P. R., & Kim, B. H. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02764-7 · Cited by 18
Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology
Edelman, S. V., Cheatham, W. W., Norton, A., & Close, K. L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0003 · Cited by 18
Roadmap to the Effective Use of Continuous Glucose Monitoring in Primary Care
Martens, T. W. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0001 · Cited by 18
A Team-Based Training for Continuous Glucose Monitoring in Diabetes Care: Mixed Methods Pilot Implementation Study in Primary Care Practices
Filippi, M. K., Lanigan, A. M., Oser, S. M., Alai, J., Brooks-Greisen, A., & Oser, T. K. (2023) · JMIR Formative Research · doi:10.2196/45189 · Cited by 16
Beyond Therapeutic Adherence: Alternative Pathways for Understanding Medical Treatment in Type 1 Diabetes Mellitus
Cleves-Valencia, J. J., Moreno, M. R., & Picione, R. D. L. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21030320 · Cited by 16
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
Kim, J. Y., Jin, S.-M., Kang, E. S., Kwak, S. H., Yang, Y., Yoo, J. H., Bae, J. H., Moon, J. S., Jung, C. H., Bae, J. C., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06155-y · Cited by 17
Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
Kesavadev, J., Basanth, A., Krishnan, G., Shankar, A., Sanal, G., & Jothydev, S. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01427-z · Cited by 16
Area deprivation and demographic factors associated with diabetes technology use in adults with type 1 diabetes in Germany
Auzanneau, M., Eckert, A. J., Meyhöfer, S. M., Heni, M., Gillessen, A., Schwettmann, L., Jehle, P. M., Hummel, M., & Holl, R. W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191138 · Cited by 16
Glycemic Targets and Prevention of Complications
Tsushima, Y., & Galloway, N. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae776 · Cited by 15
Effect of Multimodal App-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Systematic Review and Meta-Analysis
Bodner, E., Roth, L. M. K., Wiencke, K., Bischoff, C., & Schwarz, P. E. H. (2024) · Journal of Medical Internet Research · doi:10.2196/54324 · Cited by 15
Manual and Application-Based Carbohydrate Counting and Glycemic Control in Type 1 Diabetes Subjects: A Narrative Review
AlBabtain, S. A., Alafif, N. O., Aldisi, D. A., & ALZAHRANI, S. H. (2023) · Healthcare · doi:10.3390/healthcare11070934 · Cited by 14
Accuracy and Safety of the 15-Day CareSens Air Continuous Glucose Monitoring System
Kim, K., Lee, S., Yoo, W. S., & Park, C. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0468 · Cited by 14
Nuevas tecnologías para el diagnóstico, tratamiento y seguimiento de las enfermedades cardiovasculares
Rubio, L. F., Granero, C. L., Vidal-Pérez, R., Barrios, V., & Freixa‐Pamias, R. (2023) · Revista Española de Cardiología · doi:10.1016/j.recesp.2023.07.011 · Cited by 14
Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine
Desouza, C. V., Rosenstock, J., Kohzuma, T., & Fonseca, V. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad298 · Cited by 13
New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases
Fácila, L., Granero, C. L., Vidal-Pérez, R., Barrios, V., & Freixa‐Pamias, R. (2023) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2023.07.009 · Cited by 14
Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes
Aktürk, H. K. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0476 · Cited by 13
Removing Barriers, Bridging the Gap, and the Changing Role of the Health Care Professional with Automated Insulin Delivery Systems
Lingen, K., Maahs, D. M., Bellini, N. J., & Isaacs, D. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0440 · Cited by 13
Self-citation
Practical considerations for continuous glucose monitoring in elite athletes with type 1 diabetes mellitus: A narrative review
Brar, G., Carmody, S., Lumb, A. N., Shafik, A., Bright, C., & Andrews, R. C. (2024) · The Journal of Physiology · doi:10.1113/jp285836 · Cited by 13
Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes
de Wit, D. F., Snethlage, C. M. F., Rampanelli, E., Maasen, K., Walpot, N., van Raalte, D. H., Nieuwdorp, M., Soeters, M. R., & Hanssen, N. M. J. (2024) · Diabetologia · doi:10.1007/s00125-024-06213-5 · Cited by 13
Two-week continuous glucose monitoring-derived metrics and degree of hepatic steatosis: a cross-sectional study among Chinese middle-aged and elderly participants
Zhong, H., Zhang, K., Lin, L., Yan, Y., Shen, L., Chen, H., Liang, X., Chen, J., Miao, Z., Zheng, J., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02409-6 · Cited by 15
Self-healing hydrogels loaded with selenium nanoparticles/chitosan/cellulose nanofibers as carriers of mesenchymal stem cells for diabetic wound healing
Bi, J., Wang, H., Luo, H., Qian, C., Zhou, J., Li, X., Qi, X., Song, S., & Cao, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146905 · Cited by 13
Continuous glucose monitoring
Lewis, D. M., Oser, T. K., & Wheeler, B. J. (2023) · BMJ · doi:10.1136/bmj-2022-072420 · Cited by 13
Prediction of Hypoglycemia From Continuous Glucose Monitoring in Insulin-Treated Patients With Type 2 Diabetes Using Transfer Learning on Type 1 Diabetes Data: A Deep Transfer Learning Approach
Thomsen, H. B., Jakobsen, M. M., Hecht-Pedersen, N., Jensen, M. H., & Kronborg, T. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231215324 · Cited by 12
Diabetes Technology in People with Type 2 Diabetes: Novel Indications
Agarwal, S., Galindo, R. J., Shah, A. V., & Abreu, M. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01536-4 · Cited by 12
eHealth Literacy and Its Association With Demographic Factors, Disease-Specific Factors, and Well-Being Among Adults With Type 1 Diabetes: Cross-Sectional Survey Study
Stephen, D. A., Nordin, A., Johansson, U., & Nilsson, J. (2025) · JMIR Diabetes · doi:10.2196/66117 · Cited by 12
The role of technology in the care of diabetes mellitus in pregnancy: an expert review
Thayer, S. M., Williams, K. J., & Lawlor, M. L. (2023) · AJOG Global Reports · doi:10.1016/j.xagr.2023.100245 · Cited by 12
System Architecture of TWIN: A New Digital Twin-Based Clinical Decision Support System for Type 1 Diabetes Management in Children
Cappon, G., Pellizzari, E., Cossu, L., Sparacino, G., Deodati, A., Schiaffini, R., Cianfarani, S., & Facchinetti, A. (2023) · Wearable and Implantable Body Sensor Networks · doi:10.1109/bsn58485.2023.10331272 · Cited by 12
Blood glucose monitoring devices: current considerations
Sly, B., & Taylor, J. (2023) · Australian Prescriber · doi:10.18773/austprescr.2023.013 · Cited by 11
ChatGPT-4o as a digital health tool for diabetes technology education: insights on reliability, quality, and readability
Tekin, S., Oğuz, S. H., & Dağdelen, S. (2025) · Endocrine · doi:10.1007/s12020-025-04400-x · Cited by 11
Efficacy of the hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysis
Ferreira, R. O. M., Trevisan, T., Pasqualotto, E., Schmidt, P., Pedrotti, M., Watanabe, J. M. F., & van de Sande‐Lee, S. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0280 · Cited by 12
Clinical practice recommendations for management of Diabetes Mellitus in Arab region: An expert consensus statement from Arab Diabetes Forum (ADF)
Elsherif, I., Jammah, A. A., Ibrahim, A. R., Alawadi, F., Sadek, I. S., Rahman, A. M., Sharify, G. E., AlFeky, A., Aldossari, K. K., Roushdy, E., et al. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.06.003 · Cited by 11
Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin
Kim, J. Y., Ilham, S., Alshannaq, H. A., Pollock, R. F., Ahmed, W., Norman, G. J., Jin, S., & Kim, J. H. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2405293 · Cited by 11
The Limited Utility of Hemoglobin A1c as a Predictor for Periprosthetic Joint Infection Following Total Joint Arthroplasty: A Continuous Variable Analysis
Palmer, R. C., Telang, S. S., Ball, J. R., Wier, J. R., Lieberman, J. R., & Heckmann, N. D. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.01.004 · Cited by 11
Regulation of peripheral glucose levels during human sleep
Yang, X., Fedumenti, F. T., Niethard, N., Hallschmid, M., Jan Born, A., & Rauss, K. S. (2025) · SLEEP · doi:10.1093/sleep/zsaf042 · Cited by 11
Protocol for a prospective, multicenter, parallel-group, open-label randomized controlled trial comparing standard care with Closed lOoP In chiLdren and yOuth with Type 1 diabetes and high-risk glycemic control: the CO-PILOT trial
Boucsein, A., Zhou, Y., Haszard, J. J., Jefferies, C., Wiltshire, E. J., Styles, S. E., Crocket, H. R., Galland, B. C., Pasha, M., Petrovski, G., et al. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01397-4 · Cited by 10
Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time
Kovatchev, B. P., & Lobo, B. J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0117 · Cited by 10
Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop Delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life Context
Benioudakis, E. S., Karlafti, E., Kalaitzaki, A. E., Kalpou, M.-A., Georgiou, E. D., Savopoulos, C. G., & Didangelos, T. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230531161858 · Cited by 11
Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systems
Papa, G. F. S., Cannarella, R., Condorelli, R. A., Finocchiaro, C., Calogero, A. E., & Vignera, S. L. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110907 · Cited by 10
Health literacy of patients using continuous glucose monitoring
Evans, E. I., Pincus, K. J., Seung, H., & Rochester-Eyeguokan, C. D. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102109 · Cited by 10
Roadmap to the Effective Use of Continuous Glucose Monitoring by Diabetes Care and Education Specialists as Technology Champions
Albanese-O’Neill, A. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0006 · Cited by 9
Metabolic Outcomes in Pediatric Patients One-Year Post-Total Pancreatectomy with Islet Autotransplantation after Early Pump Initiation
TELLEZ, S. E., Hornung, L. N., Abu‐El‐Haija, M. A., & Elder, D. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093319 · Cited by 9
Knowledge, attitude, and practice of insulin among diabetic patients and pharmacists in Egypt: “cross-sectional observational study”
Mohamed, A. H. A., Abbassi, M., & Sabry, N. A. (2024) · BMC Medical Education · doi:10.1186/s12909-024-05367-5 · Cited by 9
AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes
Pangrace, M., Dolan, S., Grace, T., Greene, E., Long, E., McClelland, S., Moore, J., Morgan, D. E., Mullins, H., & Wescott, S. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.1-a.s1 · Cited by 9
Discordance between Glucose Management Indicator and Glycated Hemoglobin in a Pediatric Cohort with Type 1 Diabetes: A Real-World Study
Randazzese, S. F., Bombaci, B., Costantino, S., Giorgianni, Y., Lombardo, F., & Salzano, G. (2024) · Children · doi:10.3390/children11020210 · Cited by 10
Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes using continuous glucose monitoring systems
Lin, Y. K., Hepworth, E., de Zoysa, N., McCurley, J. L., Vajravelu, M. E., Ye, W., Piatt, G., Amiel, S. A., Fisher, S. J., Pop‐Busui, R., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111596 · Cited by 10
A combined diabetes and continuous glucose monitoring education program for adults with type 2 diabetes
Lind, N., Christensen, M. B., & Nørgaard, K. (2024) · PEC Innovation · doi:10.1016/j.pecinn.2024.100324 · Cited by 10
Roadmap to Achieving Continuous Glucose Monitoring Equity: Insights From the T1D Exchange Quality Improvement Collaborative
Ebekozien, O. A. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0002 · Cited by 9
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications
Gugelmo, G., Maines, E., Boscari, F., Lenzini, L., Fadini, G. P., Burlina, A., Avogaro, A., & Vitturi, N. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09903-y · Cited by 8

Authors: ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., & Gabbay, R. A.
ORCID: ElSayed, Nuha A.
Aleppo, Grazia
Aroda, Vanita R.
Bannuru, Raveendhara R.
Brown, Florence M.
Bruemmer, Dennis
Collins, Billy S.
Hilliard, Marisa E.
Isaacs, Diana
Johnson, Eric L.
Kahan, Scott
Khunti, Kamlesh
Lyons, Sarah K.
Perry, Mary Lou
Prahalad, Priya
Pratley, Richard E.
Seley, Jane Jeffrie
Stanton, Robert C.
Gabbay, Robert A.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2022-12-12
Volume: 46
Issue: Supplement_1
Pages: S111-S127
ISSN: 0149-5992 (ISSN-L)
DOI: 10.2337/dc23-s007
PMC: PMC9810474
OpenAlex: W4311264017
Cited by: 301
References: 258
Citations by year: 2026: 20 · 2025: 55 · 2024: 132 · 2023: 93 · 2022: 1
FWCI: 10.00
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.diabetesjournals.org/journals/pages/license (vor)
Locations: Diabetes Care (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: diabetes technology, diabetes management, clinical guidelines, quality of care, treatment goals
MeSH terms: Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

7. Diabetes Technology: Standards of Care in Diabetes — 2023

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks